Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cleveland Clinic Journal of Medicine
This article illustrates a case of bullosis diabeticorum, spotlighting the condition’s clinical presentation, diagnosis, and management, offering key insights for physicians in the early detection and care of this rare diabetic complication.
Dermatology March 13th 2024
The New England Journal of Medicine
The REVIVE trial elucidates rusfertide’s capacity to maintain hematocrit levels below 45% during its 28-week study period, underscoring its potential as a transformative agent in the treatment of polycythemia vera. This efficacy, coupled with a favorable safety profile, marks a significant advancement in therapeutic options for this chronic condition.
Hematology March 4th 2024
Necrobiosis lipoidica, while commonly associated with diabetes, can also present in non-diabetic individuals, as illustrated by this patient’s 13-year journey from diagnosis to spontaneous resolution.
Dermatology January 11th 2024
Epoch Health
Stiff-person syndrome, a rare yet impactful neurological disorder, presents a unique intersection with various autoimmune diseases. Understanding its symptoms and treatment strategies is crucial for patient care.
Neurology January 8th 2024
Rare Disease Advisor
Uncover the groundbreaking advancements in PNH treatment, from oral therapies to dual inhibition strategies, and their implications for patient outcomes.
Hematology January 2nd 2024
In a recent breakthrough study, thalidomide has been shown to significantly reduce recurrent bleeding in patients with small-intestinal angiodysplasia. This could pave the way for more effective treatments in the future.
Gastroenterology November 8th 2023